Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Colloids and Surfaces. B, Biointerfaces
|
September 7, 2021
Calcium phosphate-polymeric nanoparticle system for co-delivery of microRNA-21 inhibitor and doxorubicin
Vishnu Sriram, Joo-Youp Lee
Bioorganic Chemistry
|
July 5, 2022
Modified peroxamide-based reactive oxygen species (ROS)-responsive doxorubicin prodrugs
Mina Jafari, Vishnu Sriram, Gurdat Premnauth, et al.
Carbohydrate Polymers
|
September 16, 2020
Fucoidan-Doxorubicin Nanoparticles Targeting P-Selectin for Effective Breast Cancer Therapy
Mina Jafari, Vishnu Sriram, Zhenyuan Xu, et al.
Colloids and Surfaces. B, Biointerfaces
|
December 8, 2017
Modulation of in vitro phagocytic uptake and immunogenicity potential of modified Herceptin<sup>®</sup>-conjugated PLGA-PEG nanoparticles for drug delivery
Apurva Badkas, Evan Frank, Zilan Zhou, et al.
Molecular Pharmaceutics
|
October 28, 2017
Delayed Sequential Co-Delivery of Gefitinib and Doxorubicin for Targeted Combination Chemotherapy
Zilan Zhou, Mina Jafari, Vishnu Sriram, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Colloids and Surfaces. B, Biointerfaces
|
September 7, 2021
Calcium phosphate-polymeric nanoparticle system for co-delivery of microRNA-21 inhibitor and doxorubicin
Vishnu Sriram, Joo-Youp Lee
Bioorganic Chemistry
|
July 5, 2022
Modified peroxamide-based reactive oxygen species (ROS)-responsive doxorubicin prodrugs
Mina Jafari, Vishnu Sriram, Gurdat Premnauth, et al.
Carbohydrate Polymers
|
September 16, 2020
Fucoidan-Doxorubicin Nanoparticles Targeting P-Selectin for Effective Breast Cancer Therapy
Mina Jafari, Vishnu Sriram, Zhenyuan Xu, et al.
Colloids and Surfaces. B, Biointerfaces
|
December 8, 2017
Modulation of in vitro phagocytic uptake and immunogenicity potential of modified Herceptin<sup>®</sup>-conjugated PLGA-PEG nanoparticles for drug delivery
Apurva Badkas, Evan Frank, Zilan Zhou, et al.
Molecular Pharmaceutics
|
October 28, 2017
Delayed Sequential Co-Delivery of Gefitinib and Doxorubicin for Targeted Combination Chemotherapy
Zilan Zhou, Mina Jafari, Vishnu Sriram, et al.
Page
of 1